Clinical Trial Update: A Treatment Extension Study of Mucopolysaccharidosis Type IIIB [Phase 2]

View source ↗

Summary

A Phase 2 treatment extension study for Mucopolysaccharidosis Type IIIB (MPS IIIB) is being conducted, with the status and detailed results not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Type Iiib

Snippet

Sponsor: Allievex Corporation | Conditions: Mucopolysaccharidosis Type IIIB, MPS III B | Phase 2 | Status: UNKNOWN